Mavorixafor
Drug timelines are a Plus or Pro feature.
6 regulatory and trial events tracked for Mavorixafor, covering 2024-08-27 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: A Study of Mavorixafor in Participants With Congenital and Acquired Primary Autoimmune and Idiopathic Chronic Neutropenic Disorders Who Are Experiencing Recurrent and/or Serious Infections [Phase 3]